Left Menu
Development News Edition

People with fever, pregnant and breastfeeding women avoid

Bharat Biotechs fact sheet onCOVID-19 vaccine Covaxin, has advised pregnant orbreastfeeding women, besides people with high fever orbleeding disorders, not to take the antidote.The vaccine maker in the fact sheet on Covaxin, posted inits website, said the clinical efficacy of the vaccine is yetto be established and is being studied in Phase 3 clinicaltrial and hence it is important to appreciate that receivingthe vaccine does not mean other precautions related to COVID-19 need not be followed.You should not get Bharat Biotechs COVID-19 vaccineCovaxin if you have any history of allergies.

PTI | Hyderabad | Updated: 19-01-2021 11:28 IST | Created: 19-01-2021 11:28 IST
People with fever, pregnant and breastfeeding women avoid

Bharat Biotech's fact sheet onCOVID-19 vaccine Covaxin, has advised pregnant orbreastfeeding women, besides people with high fever orbleeding disorders, not to take the antidote.

The vaccine maker in the fact sheet on Covaxin, posted inits website, said the clinical efficacy of the vaccine is yetto be established and is being studied in Phase 3 clinicaltrial and hence it is important to appreciate that receivingthe vaccine does not mean other precautions related to COVID-19 need not be followed.

''You should not get Bharat Biotech's COVID-19 vaccineCovaxin if you have any history of allergies. Have high fever.

Have bleeding disorder or are a blood thinner.

Immune compromised or are a medicine that affects yourimmune system. Are pregnant. Are breast feeding.

Have received another COVID-19 vaccine. Any other serioushealth related issues, as determined by the vaccinator/Officer supervising vaccination,'' the fact sheet said.

The fact sheet also asked people to inform the vaccinatoror a supervising official about their medical condition beforetaking the vaccine.

Bharat Biotech said in an ongoing clinical trial Covaxinhas been shown to generate immunity following two doses givenfour weeks apart.

Covaxin is a vaccine with approval for restricted use inemergency situations that may prevent COVID-19.

The Central Licensing Authority has granted permissionfor the sale or distribution of the antidote for restricteduse in emergency situations in public interest as an abundantprecaution, in clinical trial mode, the fact sheet said.

Covaxin is a highly purified and inactivated two-doseSARS-CoV-2 vaccine, manufactured in a Vero cell manufacturingplatform with an excellent safety track record of more than300 million doses, the company had said.

Covaxin is India's totally indigenous COVID-19 vaccinedeveloped in collaboration with the Indian Council of MedicalResearch and National Institute of Virology.

The inactivated vaccine is developed and manufactured inBharat Biotech's BSL-3 (Bio-Safety Level 3) biocontainmentfacility, one of its kind in the world.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

Bharat Biotech has secured a fresh letter of comfort from the Centre to supply another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said.PTI GDK ROH ROH

Bharat Biotech has secured a fresh letter of comfort from the Centre to supply another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said.PTI GDK ROH ROH...

Agritech firm DeHaat raises USD 30 mn to fund its expansion plan

Agritech firm DeHaat on Tuesday said it has raised USD 30 million around Rs 220 crore from various investors to fund its expansion plan and strengthen technology platform.The company raised USD 30 million in Series C funding, led by Prosus ...

Chhattisgarh: Two women Naxals arrested in Bijapur

Police have arrested two womenNaxals, including a key cadre carrying a reward of Rs 8 lakhon her head and wanted for attacks on police personnel, inChhattisgarhs Bijapur district, an official said on Tuesday.Joint teams of the District Rese...

Ind vs Aus, 4th Test: Gill definitely deserved a century, says Laxman

Former India batsman VVS Laxman praised opener Shubman Gill for his gritty knock against Australia in the fourth and final Test at the Gabba on Tuesday. Gill fell nine runs short of his maiden Test hundred but made sure India was right on t...

Give Feedback